CBD shown to curb alcohol cravings? phase 2 trial launches.

NCT ID NCT07279558

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether cannabidiol (CBD) can help people who drink alcohol regularly cut down on their drinking. Researchers are giving 150 adults either full-spectrum CBD, broad-spectrum CBD, or a placebo daily for 12 weeks. They will measure how much participants drink in a lab setting and through self-reports, as well as blood markers of alcohol use. The goal is to see if CBD can be a safe, effective tool for managing alcohol use disorder.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cannabidiol (CBD) – either full-spectrum (with trace THC) or broad-spectrum (no THC)
What this could lead to
If it works, this could point toward a new, non-addictive option to help people drink less and avoid alcohol-related harm.
What could go wrong
This is a mid-stage trial with only 150 participants, so results may not apply to everyone. CBD may not reduce drinking more than a placebo, and some people may experience side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Colorado School of Medicine- Anschutz Medical Campus

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.